Evidence map›Paper›PMID 23180115›Full record

ReviewSurgery today2014

Pancreatic metastases of cerebellar hemangiopericytoma occurring 24 years after initial presentation: report of a case.

Takanori Hiraide, Takanori Sakaguchi, Yasushi Shibasaki, Yoshifumi Morita, Atsushi Suzuki, Keisuke Inaba, Tsutomu Tokuyama, Satoshi Baba, Shohachi Suzuki, Hiroyuki Konno

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Surgery today, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Sarcoma metastasis to the pancreas: experience at a single institution.Journal of pathology and translational medicine · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Takanori HiraideSecond Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan, hiraide@hama-med.ac.jp.
Takanori Sakaguchi
Yasushi Shibasaki
Yoshifumi Morita
Atsushi Suzuki
Keisuke Inaba
Tsutomu Tokuyama
Satoshi Baba
Shohachi Suzuki
Hiroyuki Konno
Hamamatsu University · JPHamamatsu University School of Medicine · JPIwata City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemangiopericytoma (HPC) preferentially developing in soft tissues and the meninges has been gradually recognized to be an aggressive, highly metastatic tumor. We herein report the case of a 65-year-old male with pancreatic metastases of cerebellar HPC that developed following two resections of intracranial local recurrent foci, 24 years after the initial craniotomy and 7 years after resection of metastases to the lungs and kidneys. Follow-up abdominal computed tomography scanning and magnetic resonance imaging revealed a solitary tumor in the pancreatic body. Since no other recurrent foci were detectable, distal pancreatectomy was performed. Another metastasis was incidentally found in the resected pancreas. Both foci were pathologically proven to be metastases of HPC. Among the 12 reported cases of pancreatic metastases of HPC, including ours, this case showed the longest duration between initial onset and the development of pancreatic metastases, suggesting that providing long-term follow-up is necessary for HPC patients.

Indexed as

AgedCerebellar NeoplasmsFluorine RadioisotopesFluorodeoxyglucose F18Follow-Up StudiesHemangiopericytomaHumansMagnetic Resonance ImagingPancreatectomyPancreatic NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsTime FactorsTomography, X-Ray ComputedTreatment OutcomeFluorine RadioisotopesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID23180115
OpenAlexW2093942660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.